SRT2104通过增强Sirt1介导的去乙酰化对小鼠缺血/再灌注损伤的神经保护作用
本研究在小鼠视网膜缺血/再灌注(I/R)损伤模型中,于I/R诱导后立即玻璃体腔注射SRT2104,检测其对视网膜结构、功能及细胞凋亡、衰老和神经炎症的影响。结果显示SRT2104通过增强Sirt1蛋白稳定性、逆转p53、NF-κB p65和STAT3乙酰化,显著保护内层视网膜结构和神经元、部分恢复视网膜功能,并减轻凋亡、衰老和神经炎症。
要点
- SRT2104玻璃体腔注射可显著保护I/R损伤后的内层视网膜结构和神经元,并部分恢复视网膜功能。
- SRT2104减轻I/R诱导的细胞凋亡、衰老及神经炎症(反应性胶质增生、血管炎症、促炎因子过表达)。
- 机制上SRT2104增强Sirt1蛋白稳定性,逆转p53、NF-κB p65和STAT3的乙酰化。
核心结论
- SRT2104通过增强Sirt1介导的去乙酰化、抑制凋亡、衰老和神经炎症相关通路,对I/R损伤发挥有效保护作用。
研究设计与样本
- 小鼠视网膜缺血/再灌注(I/R)损伤模型,I/R诱导后立即玻璃体腔注射SRT2104。
- 采用定量实时PCR和Western blot检测RNA和蛋白表达,免疫荧光染色检测蛋白表达与分布。
- 采用苏木精-伊红染色、光学相干断层扫描和视网膜电图分析视网膜结构与功能,甲苯胺蓝染色定量视神经轴突。
- 采用TUNEL法和SA-β-gal染色评估细胞凋亡与衰老。
主要发现
- I/R损伤后Sirt1蛋白表达显著下降,SRT2104给药有效增强Sirt1蛋白稳定性,而不显著影响Sirt1 mRNA合成。
- 单独给予SRT2104对正常视网膜的结构和功能无影响。
- SRT2104干预显著保护内层视网膜结构和神经元,并部分恢复I/R损伤后的视网膜功能。
- SRT2104有效减轻I/R诱导的细胞凋亡和衰老,并显著减少神经炎症,包括反应性胶质增生、视网膜血管炎症和促炎细胞因子过表达。
- SRT2104显著逆转I/R诱导的p53、NF-κB p65和STAT3乙酰化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence information regulator 1 (Sirt1). Here, we investigated whether SRT2104 could protect the retina from ischemia/reperfusion (I/R) injury and the underlying mechanisms. METHODS: SRT2104 was intravitreally injected immediately after I/R induction. RNA and protein expression were detected by quantitative real-time PCR and Western blot. Protein expression and distribution were examined by immunofluorescence staining. Retinal structure and function were analyzed by hematoxylin and eosin staining, optical coherence tomography, and electroretinogram. Optic nerve axons were quantified using toluidine blue staining. Cellular apoptosis and senescence were evaluated by TUNEL assay and SA-β-gal staining. RESULTS: The protein expression of Sirt1 decreased dramatically after I/R injury and SRT2104 administration effectively enhanced the stability of Sirt1 protein without significantly influencing Sirt1 mRNA synthesis. SRT2104 administration alone exerted no influence on the structure and function of normal retinas. However, SRT2104 intervention significantly protected the inner retinal structure and neurons; partially restored retinal function after I/R injury. I/R-induced cellular apoptosis and senescence were effectively alleviated by SRT2104 administration. Additionally, SRT2104 intervention markedly reduced neuroinflammation, including reactive gliosis, retinal vascular inflammation, and the overexpression of pro-inflammatory cytokines after I/R injury. Mechanistically, I/R-induced acetylation of p53, NF-κB p65, and STAT3 was significantly reversed by SRT2104 intervention. CONCLUSIONS: We demonstrated that SRT2104 exerted potent protective effects against I/R injury by enhancing Sirt1-mediated deacetylation and suppressing apoptosis, senescence, and neuroinflammation-related pathways.
引用
- Bai X, Ye D, Shi Y, et al. Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation. Invest Ophthalmol Vis Sci. 2023. PMID: 37099021. doi:10.1167/iovs.64.4.31
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。